Pharmacokinetic changes of cyclosporine after intravenous and oral administration to rats with uranyl nitrate-induced acute renal failure

Int J Pharm. 2000 Jan 25;194(2):221-7. doi: 10.1016/s0378-5173(99)00382-8.

Abstract

The effects of renal failure on the pharmacokinetics of cyclosporine were investigated after intravenous, 30 mg/kg, and oral, 100 mg/kg, administration of the drug using a rat model of uranyl nitrate-induced acute renal failure (U-ARF). After intravenous administration to rats with U-ARF, the volume of distribution at steady state (1.97 vs. 2.56 l/kg) was significantly smaller, and the area under the blood concentration-time curve (348 vs. 296 microg h/ml) tended to be greater and total body clearance (0.0851 vs. 0. 102 l/h per kg) tended to be slower than those in control rats. After oral administration, the pharmacokinetic parameters were not significantly different between the control rats and rats with U-ARF, suggesting that U-ARF did not considerably affect the pharmacokinetics of cyclosporine after oral administration.

MeSH terms

  • Acute Kidney Injury / metabolism*
  • Administration, Oral
  • Animals
  • Cyclosporine / administration & dosage
  • Cyclosporine / pharmacokinetics*
  • Immunosuppressive Agents / pharmacokinetics*
  • Injections, Intravenous
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Uranyl Nitrate

Substances

  • Immunosuppressive Agents
  • Uranyl Nitrate
  • Cyclosporine